Rakovina Therapeutics Inc. will host a 60-minute webinar on December 17, 2025 at 10:00 AM PST. The session, titled “From Handshake to Breakthrough,” will feature a discussion on creating CNS-penetrant, multi-target cancer therapeutics using AI-designed ATR/mTOR inhibitors. The webinar will include a Q&A session for participants to engage with both organizations. Rakovina Therapeutics focuses on developing innovative cancer treatments using AI-powered drug discovery. The company aims to advance drug candidates into human clinical trials in collaboration with pharmaceutical partners. For more information, visit www.rakovinatherapeutics.com.

Read more at GlobeNewswire: Rakovina Therapeutics Announces Upcoming Webinar with